TEM screens as a clean technical entry. Price is holding above the Kijun, the forward cloud is twisting from red to green, and momentum is confirming rather than stretched: RSI near 58 is rising with room before overbought, and MACD has turned positive.
The honest caveat is that the breakout above the multi-month consolidation has already triggered, so the easy near-term pop is largely behind it. This is an early-breakout entry, not a coiled-spring setup — which argues for patience on execution.
A better entry likely comes on weakness: a retest back toward the $52–53 breakout zone would offer more favorable risk/reward than paying up at $56.
The runway is structural and layered. The higher-probability near-term move is a reversion up to the 200-day moving average — the first overhead magnet — before more significant resistance comes into play. Beyond that, Wall Street consensus sits in the high-$60s to low-$70s (24-analyst average ~$72) against a current $56, leaving meaningful upside if the AI-targeted healthcare thesis plays out over the intermediate term
The honest caveat is that the breakout above the multi-month consolidation has already triggered, so the easy near-term pop is largely behind it. This is an early-breakout entry, not a coiled-spring setup — which argues for patience on execution.
A better entry likely comes on weakness: a retest back toward the $52–53 breakout zone would offer more favorable risk/reward than paying up at $56.
The runway is structural and layered. The higher-probability near-term move is a reversion up to the 200-day moving average — the first overhead magnet — before more significant resistance comes into play. Beyond that, Wall Street consensus sits in the high-$60s to low-$70s (24-analyst average ~$72) against a current $56, leaving meaningful upside if the AI-targeted healthcare thesis plays out over the intermediate term
Aviso legal
As informações e publicações não se destinam a ser, e não constituem, conselhos ou recomendações financeiras, de investimento, comerciais ou de outro tipo fornecidos ou endossados pela TradingView. Leia mais nos Termos de Uso.
Aviso legal
As informações e publicações não se destinam a ser, e não constituem, conselhos ou recomendações financeiras, de investimento, comerciais ou de outro tipo fornecidos ou endossados pela TradingView. Leia mais nos Termos de Uso.